http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2519186-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9255994893bc559e4608e627388ba146
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J17-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba9b99c4112c3235ef723bd1ec7cb1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_223ff3ba89e7eee756191c2b7ea92aa4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f21cb702c41da6f3edb6a8dfbaa00bcf
publicationDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2519186-C2
titleOfInvention Cholestanol derivative for combined administration
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an anticancer chemotherapeutic agent containing a combination of a cholestanol derivative presented by the formula n , n wherein G represents GlcNAc-Gal- or GlcNAc-, or its cyclodextrin inclusion compound, and irinotecan. n EFFECT: anticancer chemotherapeutic agent has excellent efficacy and fewer side effects. n 7 cl, 6 ex, 9 dwg
priorityDate 2009-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1921086-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2240793-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467317447

Total number of triples: 38.